ResearcherCatharina ZiekenhuisNo recent work listed
Maikel J. A. M. Bakens
Matched on ORCID iD 0009-0002-4028-5058; OpenAlex author ID A5014008125. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2015: 1 paper · 2016: 1 paper · 2017: 2 papers
Papers 4
- Low skeletal muscle radiation attenuation and visceral adiposity are associated with overall survival and surgical site infections in patients with pancreatic … First author DOI 10.1002/jcsm.12155↗
- Socio-economic status influences the likelihood of undergoing surgical treatment for pancreatic cancer in the Netherlands. Co-author DOI 10.1016/j.hpb.2017.01.010↗
- The use of adjuvant chemotherapy for pancreatic cancer varies widely between hospitals: a nationwide population-based analysis. Co-author DOI 10.1002/cam4.921↗
- Hospital of diagnosis and likelihood of surgical treatment for pancreatic cancer. Co-author DOI 10.1002/bjs.9951↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- V.E.P.P. Lemmens · 3 shared papers, 2015–2017 · strength 0.23
- Paper Socio-economic status influences the likelihood of undergoing surgical treatment for pancreatic cancer in the Netherlan… DOI 10.1016/j.hpb.2017.01.010↗
- Paper The use of adjuvant chemotherapy for pancreatic cancer varies widely between hospitals: a nationwide population-based a… DOI 10.1002/cam4.921↗
- Paper Hospital of diagnosis and likelihood of surgical treatment for pancreatic cancer. DOI 10.1002/bjs.9951↗
- Ignace H. J. T. de Hingh · 3 shared papers, 2015–2017 · strength 0.23
- Paper Socio-economic status influences the likelihood of undergoing surgical treatment for pancreatic cancer in the Netherlan… DOI 10.1016/j.hpb.2017.01.010↗
- Paper The use of adjuvant chemotherapy for pancreatic cancer varies widely between hospitals: a nationwide population-based a… DOI 10.1002/cam4.921↗
- Paper Hospital of diagnosis and likelihood of surgical treatment for pancreatic cancer. DOI 10.1002/bjs.9951↗
- Cornelis H.C. Dejong · 2 shared papers, 2015–2017 · strength 0.12
- Marc G. Besselink · 2 shared papers, 2015–2016 · strength 0.11
- David P.J. van Dijk · 1 shared paper, 2017 · strength 0.07
- Steven W.M. Olde Damink · 1 shared paper, 2017 · strength 0.07
- Sander S. Rensen · 1 shared paper, 2017 · strength 0.07
- Geert‐Jan Creemers · 1 shared paper, 2016 · strength 0.06
- Hanneke W.M. van Laarhoven · 1 shared paper, 2016 · strength 0.06
- Lydia G. van der Geest · 1 shared paper, 2016 · strength 0.06
- Izaak Quintus Molenaar · 1 shared paper, 2015 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.